TPD & Induced Proximity Summit Leaderboard
  • Saturday, July 18, 2026
  • About
  • Advertise
  • Subscribe
  • Contact

Pharma Journalist Pharma Journalist -

Oligonucleotides Analytical Development & CMC Summit Leaderboard
  • Home
  • News
  • Drug Research
  • Clinical Trials
  • Manufacturing
  • Information Technology
  • Packaging & Labeling
  • Diseases
  • Resources
    • Articles
    • Projects
    • Case Studies
    • Industry Reports
    • Interviews
    • White Papers
  • Events
  • Press Releases
Pharma Journalist
  • Home
  • Pharma Journalist
  • Page 551

Author

Pharma Journalist 8947 posts 0 comments

Bayer and WuXi Biologics enter into an agreement on a Leverkusen drug product plant

Jan 16, 2020
Bayer and WuXi Biologics have entered into an agreement that WuXi Biologics Germany GmbH will take over operations of one of Bayer’s final drug product manufacturing plants in…
Read More...

Sun Pharma and Rockwell Medical enter into licensing agreement for Triferic in India

Jan 16, 2020
Sun Pharmaceutical Industries Ltd. announced that one of its wholly owned subsidiaries has entered into exclusive licensing and supply agreements with Rockwell Medical Inc. (Rockwell),…
Read More...

NuMedii Announces Pharmaceutical Discovery Collaboration For Ulcerative Colitis

Jan 16, 2020
NuMedii, Inc. announced a new partnership with a drug delivery company to develop new therapeutics for ulcerative colitis. The collaboration will bring together NuMedii's NM-001 asset…
Read More...

Artisan Bio Announces Global Research and Discovery Collaboration Agreement with Takeda to Develop…

Jan 16, 2020
Artisan Bio, Inc., a stealth cell therapy engineering company, announced it has entered into a global research and collaboration agreement with Takeda Pharmaceutical Company Limited for…
Read More...

FDA grants priority review for AstraZeneca’s Lynparza

Jan 16, 2020
AstraZeneca and MSD Inc., Kenilworth, N.J., US announced that a supplemental New Drug Application for Lynparza (olaparib) in combination with bevacizumab has been accepted and granted…
Read More...

Fibrocor and Galapagos sign expanded collaboration in fibrosis

Jan 16, 2020
Galapagos NV and Fibrocor Therapeutics Inc. announced an expanded collaboration focused on novel targets in fibrosis, with Galapagos taking an equity stake in Fibrocor. Fibrocor is a…
Read More...

Clovis Oncology’s Rubraca (Rucaparib) Granted FDA Priority Review For Advanced Prostate Cancer

Jan 16, 2020
Clovis Oncology announced that the U.S. Food and Drug Administration (FDA) has accepted the company’s supplemental New Drug Application (sNDA) for Rubraca (rucaparib) and granted…
Read More...

Dermavant Enters into Exclusive License Agreement with JT for Development and Commercialization of…

Jan 16, 2020
Dermavant Sciences, a dermatology-focused subsidiary of Roivant Sciences, announced that it has entered into a collaboration and license agreement with Japan Tobacco Inc. (JT) for…
Read More...

ASC Therapeutics and Vigene Announce Long-Term Strategic Partnership for Gene Therapy Development…

Jan 15, 2020
ASC Therapeutics announced that it has entered into a long-term strategic manufacturing partnership with Vigene Biosciences, a Maryland-based Contract Develop and Manufacturing…
Read More...

ProBioGen and Lava Therapeutics Sign Cell Line Development and GMP Manufacturing Agreement for Novel…

Jan 15, 2020
ProBioGen AG and Lava Therapeutics B.V. announced the closing of a cell line development and manufacturing agreement for Lava’s novel bispecific antibody lead candidate. Founded in…
Read More...
Prev Next
RNA-Based Therapeutics & Vaccines Summit South Korea
RNA-Targeted Drug Discovery & Development Summit
mRNA Process Development & CMC Summit 2026
TPD & Induced Proximity Summit
Measuring Patient Engagement Summit Europe
Oligonucleotides Analytical Development & CMC Summit
11th CAR-TCR Summit
COPD Drug Development Summit
2nd Operationalize: Expanded Access Programs Summit West
Neuropsychiatric Drug Development Summit
International Neoantigen Summit
Lab Ops & Facility Management for Biopharma West Summit
10th IPF Summit
Medical Device Software Development Summit
Liquid Biopsy for Precision Oncology Summit East Coast
ADC Linker & Conjugation Summit
Cell & Gene Therapy Summit South Korea
10th Dermatology Drug Development Summit
9th Lab Asset & Facility Management Summit
TRP Supply Chain & Manufacturing Summit
Covalent Drug Discovery & Development Summit
7th Genome Editing Therapeutics Summit
16th World Clinical Biomarkers & Companion Diagnostics Summit
Lipid Nanoparticles Development Summit Europe
iPSC Drug Development Summit
17th World ADC San Diego
Oligonucleotides for CNS Summit
In Vivo Cell Engineering & Gene Editing Summit
Obesity & Weight Loss Drug Development Summit
T-Cell Engager Therapeutics Summit
mRNA-Based Therapeutics Summit
About Us

Pharma Journalist

Pharma Journalist is a product of Kellen Media. Pharma Journalist is one of the leading website covering the need of global Pharmaceutical Industry.

Articles like latest news, trends, analysis, market report, press releases, whitepapers, case studies, etc. published on pharmajournalist.com helps Industry professionals and decision makers to stay on the top of this fast-paced industry.

Pharma Journalist aims of providing fast and informative articles to its readers and subscribers.

Recent Posts
  • Organon Expands Australia Biosimilar Partnership With Samsung Bioepis
  • Telix Opens Advanced Cancer Radiopharmaceutical Facility in Melbourne
  • FDA Approves First Oral PCSK9 Inhibitor for High Cholesterol
  • FDA Grants Full Approval to Fabhalta for IgA Nephropathy
  • EU Approves Wegovy Pill for Obesity Treatment

Industry Reports

Amgen Acquires Dark Blue to Advance Novel AML Treatments

Takeda Expands Entyvio Options Through Halozyme Technology…

Inductive Bio Wins $21M to Build AI Drug Toxicity Models

Alkermes Boosts Offer to Acquire Avadel in Deal Worth Up to…

Novartis Completes Acquisition of Tourmaline Bio to…

Press Releases

Advancing Respiratory Medicine Following ATS – What Now?

World ADC San Diego Unveils Preliminary Agenda for 17th…

Regeneron Goes All In on Radiopharma with $2.1B Telix Deal…

IQ MPS Leaders to Share Industry Progress on Advancing In…

4th ADC Linker & Conjugation Summit Announces 2026…

  • About
  • Advertise
  • Subscribe
  • Contact
© 2026 - Pharma Journalist. All Rights Reserved.
Pharma Journalist is a product of
Sign in

Welcome, Login to your account.

Forget password?
Sign in

Recover your password.

A password will be e-mailed to you.

We use cookies to ensure that we give you the best experience on our website. If you continue to use this site we will assume that you are happy with it.